Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Joo-Cheol Shim

Showing results (11-20 of 30) with videos related to

Pageof 3
Sort By:
Schizophrenia Research|August 21, 2016
Adjunctive varenicline treatment for smoking reduction in patients with schizophrenia: A randomized double-blind placebo-controlled trialDong-Wook Jeon, Joo-Cheol Shim, Bo-Geum Kong, et al.
Schizophrenia Research|November 26, 2008
Cardiac-related findings at autopsy in people with severe mental illness treated with clozapine or risperidoneDeanna L Kelly, Heidi J Wehring, Jared Linthicum, et al.
Journal of Clinical Psychopharmacology|April 25, 2006
Combined effects of itraconazole and CYP2D6*10 genetic polymorphism on the pharmacokinetics and pharmacodynamics of haloperidol in healthy subjectsJi-Young Park, Ji-Hong Shon, Kyoung-Ah Kim, et al.
The American Journal of Psychiatry|August 31, 2007
Adjunctive treatment with a dopamine partial agonist, aripiprazole, for antipsychotic-induced hyperprolactinemia: a placebo-controlled trialJoo-Cheol Shim, Jae-Goo K Shin, Deanna L Kelly, et al.
International Journal of Psychiatry in Clinical Practice|September 22, 2015
Differences in cognitive function and daily living skills between early- and late-stage schizophreniaSung-Jin Kim, Joo-Cheol Shim, Bo-Geum Kong, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|January 16, 2007
Identification and functional characterization of genetic variants of human organic cation transporters in a Korean populationHo-Jin Kang, Im-Sook Song, Ho Jung Shin, et al.
Clinical Psychopharmacology and Neuroscience : the Official Scientific Journal of the Korean College of Neuropsychopharmacology|November 25, 2015
The Relationship between Language Ability and Cognitive Function in Patients with SchizophreniaSung-Jin Kim, Joo-Cheol Shim, Bo-Geum Kong, et al.
Journal of Psychiatric Research|May 19, 2012
Alcohol and cannabis use and mortality in people with schizophrenia and related psychotic disordersMaju Mathew Koola, Robert P McMahon, Heidi J Wehring, et al.
Asian Journal of Psychiatry|October 27, 2019
The effect of anticholinergic burden on cognitive and daily living functions in patients with schizophreniaSung-Jin Kim, Doun Jung, Joo-Cheol Shim, et al.
British Journal of Clinical Pharmacology|May 19, 2007
The effect of ABCG2 V12M, Q141K and Q126X, known functional variants in vitro, on the disposition of lamivudineHo-Sook Kim, Yu Eun Sunwoo, Ji Young Ryu, et al.
Pageof 3

Showing results (11-20 of 30) with videos related to

Sort By:
Pageof 3
Schizophrenia Research|August 21, 2016
Adjunctive varenicline treatment for smoking reduction in patients with schizophrenia: A randomized double-blind placebo-controlled trialDong-Wook Jeon, Joo-Cheol Shim, Bo-Geum Kong, et al.
Schizophrenia Research|November 26, 2008
Cardiac-related findings at autopsy in people with severe mental illness treated with clozapine or risperidoneDeanna L Kelly, Heidi J Wehring, Jared Linthicum, et al.
Journal of Clinical Psychopharmacology|April 25, 2006
Combined effects of itraconazole and CYP2D6*10 genetic polymorphism on the pharmacokinetics and pharmacodynamics of haloperidol in healthy subjectsJi-Young Park, Ji-Hong Shon, Kyoung-Ah Kim, et al.
The American Journal of Psychiatry|August 31, 2007
Adjunctive treatment with a dopamine partial agonist, aripiprazole, for antipsychotic-induced hyperprolactinemia: a placebo-controlled trialJoo-Cheol Shim, Jae-Goo K Shin, Deanna L Kelly, et al.
International Journal of Psychiatry in Clinical Practice|September 22, 2015
Differences in cognitive function and daily living skills between early- and late-stage schizophreniaSung-Jin Kim, Joo-Cheol Shim, Bo-Geum Kong, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|January 16, 2007
Identification and functional characterization of genetic variants of human organic cation transporters in a Korean populationHo-Jin Kang, Im-Sook Song, Ho Jung Shin, et al.
Clinical Psychopharmacology and Neuroscience : the Official Scientific Journal of the Korean College of Neuropsychopharmacology|November 25, 2015
The Relationship between Language Ability and Cognitive Function in Patients with SchizophreniaSung-Jin Kim, Joo-Cheol Shim, Bo-Geum Kong, et al.
Journal of Psychiatric Research|May 19, 2012
Alcohol and cannabis use and mortality in people with schizophrenia and related psychotic disordersMaju Mathew Koola, Robert P McMahon, Heidi J Wehring, et al.
Asian Journal of Psychiatry|October 27, 2019
The effect of anticholinergic burden on cognitive and daily living functions in patients with schizophreniaSung-Jin Kim, Doun Jung, Joo-Cheol Shim, et al.
British Journal of Clinical Pharmacology|May 19, 2007
The effect of ABCG2 V12M, Q141K and Q126X, known functional variants in vitro, on the disposition of lamivudineHo-Sook Kim, Yu Eun Sunwoo, Ji Young Ryu, et al.
Pageof 3